Month: April 2023

UCART22 is currently the most advanced allogeneic CAR T-cell product in development for relapsed or refractory B-cell acute lymphoblastic leukemiaThe BALLI-01 study (evaluating UCART22) is actively enrolling patients with relapsed or refractory B-cell ALL after FCA lymphodepletionNEW YORK, April 11, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that the first patient in Europe has been dosed in France with its in-house manufactured product candidate UCART22 and completed the 28-day Dose Limiting Toxicity period. “Our team has worked tirelessly to expand our BALLI-01 clinical study (evaluating UCART22) to Europe. Dosing our first...

SPARTA, N.J., April 11, 2023 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs. The Company had previously announced that on October 3, 2022, it was notified by the Listing Qualifications Department (the “Listing Qualifications Department”) of the Nasdaq Stock Market LLC (“Nasdaq”) that the Listing Qualifications Department has determined to delist the Company’s securities from Nasdaq, citing that for a period of 30 consecutive business days, the bid price of its common stock had closed below the minimum of $1.00...

MONTRÉAL, April 11, 2023 (GLOBE NEWSWIRE) — Nouveau Monde Graphite Inc. (“NMG“ or the “Company”) (NYSE: NMG, TSX.V: NOU) is pleased to announce that it has entered into an agreement with a syndicate of underwriters (the “Underwriters”) led by BMO Capital Markets and Cormark Securities Inc., pursuant to which the Underwriters have agreed to buy on a bought-deal basis 4,850,000 common shares of the Company (the “Common Shares”), at a price of US$4.55 per Common Share, for aggregate gross proceeds of approximately US$22 million (the “Offering”). The Company has granted the Underwriters an option, exercisable in whole or in part for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Common Shares offered under the Offering to cover over-allotments, if any (the “Over-Allotment Option”). The...

RALEIGH, N.C., April 11, 2023 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) today announced the release of its inaugural 2022 Environmental, Social, and Governance (ESG) Report covering the calendar year 2022. The report marks a significant step forward in the company’s ESG journey and reflects Enact’s long-standing commitment to operating with integrity, accountability and responsibility while fulfilling our core mission to help people achieve the dream of sustainable homeownership. “Enact is committed to serving as a positive force in society and holding ourselves accountable to the highest standards as we advance our mission, support our communities, and create shareholder value,” said Rohit Gupta, President and CEO of Enact. “We are very proud to issue our first ESG report as we continue to drive ESG considerations...

STEINHAUSEN, Switzerland, April 11, 2023 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) announced today that it will report earnings for the first quarter 2023 after the close of trading on the NYSE on Monday, May 1, 2023. The company will conduct a teleconference to discuss the results starting at 9 a.m. EDT, 3 p.m. CEST, on Tuesday, May 2, 2023. Individuals who wish to participate should dial +1 785-424-1634 and refer to conference code 761543 approximately 15 minutes prior to the scheduled start time. The teleconference will be simulcast in a listen-only mode at: www.deepwater.com, by selecting Investors, News, and Webcasts. A replay of the conference call will be available after 12 p.m. EDT, 6 p.m. CEST, on May 2, 2023. The replay, which will be archived for approximately 30 days, can be accessed at +1 402-220-4940, passcode...

WALTHAM, Mass., April 11, 2023 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (the “Company” or “GECC”) (NASDAQ: GECC) announced today that its 2023 Annual Stockholders’ Meeting will be held on June 1, 2023. The notice of annual meeting and proxy statement containing the meeting details are expected to be available on or about April 21, 2023 to stockholders of record as of the close of business on April 10, 2023. About Great Elm Capital Corp. GECC is an externally managed business development company that seeks to generate current income and capital appreciation by investing in debt and income generating equity securities, including investments in specialty finance businesses. Media & Investor Contact:Investor Relationsinvestorrelations@greatelmcap.com Source: Great Elm Capital Corp.

ANDOVER, Mass., April 11, 2023 (GLOBE NEWSWIRE) — Mercury Systems Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers processing power for the most demanding aerospace and defense missions, will release its third quarter fiscal year 2023 financial results after the market close on Tuesday, May 2, 2023. Management will host a conference call and simultaneous webcast at 5:00 p.m. ET on the same day to discuss Mercury’s quarterly financial results, business highlights, and outlook. In addition, Company representatives may answer questions concerning business and financial developments and trends, the Company’s view on earnings forecasts, and other business and financial matters affecting the Company, the responses to which may contain information that has not been previously disclosed. To attend the conference...

NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) — Latch, Inc. (NASDAQ: LTCH) (the “Company”), maker of LatchOS, the full-building enterprise software-as-a-service (SaaS) platform, today announced that on April 5, 2023, the Company received a decision from a Nasdaq Hearings Panel (the “Panel”) granting the Company’s request for continued listing on the Nasdaq Global Select Market, subject to the Company demonstrating compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) on or before August 4, 2023, and certain other conditions. As previously disclosed, the Company received delisting notifications from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) following the Company’s failure to timely file its Quarterly Reports on Form 10-Q for the quarterly periods ended June 30, 2022 and...

PARIS, April 11, 2023 (GLOBE NEWSWIRE) — In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) Paris, France, April 11, 2023Market: Euronext Paris / NasdaqEuronext Compartment: B ISIN code: FR0011341205Nasdaq: NBTXBloomberg: NANO:FPReuters: NANO.PAWebsite: www.nanobiotix.comDateNumber of Shares OutstandingTotal number of voting rightsTotal voting rights, theoretical1Total voting rights, exercisable2March 31, 202334,875,872 36,634,849 36,612,731According to the article L.233-8 II of the French Commercial Code, Nanobiotix will make a new monthly publication of the total number of voting rights and shares comprising Nanobiotix’s capital if those figures differ from the information previously...